Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Epilepsy in the elderly]

A Peinemann1, H Stefan

  • 1Neurologische Klinik mit Poliklinik, Friedrich-Alexander-Universität, Erlangen-Nürnberg.

Der Nervenarzt
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Epilepsy incidence rises in individuals over 60, often linked to vascular issues or tumors. Careful management of antiepileptic drugs is crucial for older adults.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimal-invasive, ablative surgery - Potential and limitations for a curative treatment approach in epilepsy.

Epilepsy research·2018
Same author

Epileptogenicity and pathology - Under consideration of ablative approaches.

Epilepsy research·2018
Same author

Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: First case report in Asian population.

Epilepsy & behavior case reports·2017
Same author

Automatic multimodal detection for long-term seizure documentation in epilepsy.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2017
Same author

Single-dose intravenous administration of antiepileptic drugs induces rapid and reversible remodeling in the brain: Evidence from a voxel-based morphometry evaluation of valproate and levetiracetam in rhesus monkeys.

Neuroscience·2015
Same author

Epilepsy in the elderly: restrictions, fears, and quality of life.

Acta neurologica Scandinavica·2014
Same journal

[When brain abscesses run in the family…].

Der Nervenarzt·2026
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[Rare genetic diseases with frequent mental symptoms].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
See all related articles

Area of Science:

  • Neurology
  • Geriatrics
  • Epileptology

Context:

  • The incidence of new epileptic disorders significantly increases in individuals over 60 years of age.
  • Vascular causes, including cerebral ischemia and hemorrhage, are the most frequent etiologies of epilepsy in the elderly.
  • Brain tumors also contribute to epilepsy in older adults, peaking around age 60.

Purpose:

  • To investigate the etiologies and characteristics of newly diagnosed epilepsy in the elderly population.
  • To highlight the importance of recognizing confusional states as potential seizure symptoms in older adults.
  • To emphasize the need for careful drug titration and simplified regimens for antiepileptic drugs in geriatric patients.

Summary:

  • Vascular events account for 32-54% of epilepsy cases in the elderly, with specific risks associated with cerebral ischemia (4-9%), intracerebral hemorrhage (3%), and subarachnoid hemorrhage (4-12%).

Related Experiment Videos

  • Tumors cause 11-33% of epilepsy cases in this age group. Approximately one-third of epilepsy cases in the elderly remain without a clear etiological diagnosis.
  • Occasional seizures are more frequent in older individuals, and confusional states may indicate psychomotor status or prolonged postictal phases.
  • Impact:

    • Informs clinical practice regarding the diagnosis and management of epilepsy in aging populations.
    • Underscores the need for vigilance in identifying seizure manifestations beyond typical convulsions in the elderly.
    • Provides guidance on optimizing pharmacotherapy for epilepsy in older adults, considering altered pharmacokinetics and compliance challenges.